Table 3.
Yes (%) |
No (%) |
Don’t know (%) |
|
---|---|---|---|
Diseases that can be tested/screened DTC | |||
Hereditary breast and ovarian cancer | 68a | 12 | 20 |
Cystic fibrosis | 48a | 9 | 43 |
Cardiovascular diseaseb | 48a | 4 | 48 |
Hemochromatosis | 46a | 1 | 53 |
Alzheimer diseaseb | 41a | 5 | 54 |
Newborn screening | 40a | 17 | 43 |
Depressionb | 20a | 9 | 70 |
Schizophreniab | 20 | 11a | 69 |
True (%) | False (%) | Don’t know (%) | |
Oversight and regulation | |||
DTC genetic testing is currently regulated by the US government | 2 | 77a | 21 |
NIH has the authority to regulate DTC genetic testing | 0 | 58a | 42 |
FTC has the authority to regulate DTC genetic testing | 47a | 0 | 53 |
FDA has authority to regulate DTC genetic testing | 21a | 30 | 48 |
All DTC genetic testing companies use CLIA approved laboratories | 8 | 50a | 42 |
Genetic testing offered DTC can be purchased internationally over the Internet | 61a | 4 | 36 |
DTC genetic testing companies must demonstrate clinical validity and utility before marketing genetic tests DTC | 6 | 67a | 27 |
True (%) | False (%) | Don’t know (%) | |
Organizations that have issued a position statement | |||
American Board of Genetic Counseling (ABGC) | 7 | 34a | 59 |
American Board of Medical Genetics (ABMG) | 5 | 24a | 71 |
American College of Medical Genetics (ACMG) | 35a | 6 | 59 |
American Society of Human Genetics (ASHG) | 21a | 8 | 71 |
National Society of Genetic Counselors (NSGC) | 73a | 7 | 20 |
NIH, National Institutes of Health; FTC, Federal Trade Commission; FDA, Food and Drug Administration; CLIA, Clinical Laboratory Improvement Amendments.
Correct response.
Not currently standard of care to offer genetic testing for condition in a clinical setting.